Sarepta Therapeutics Inc

NASDAQ:SRPT

74.66

+3.76 (+5.30%)

Earnings Announcements

Sarepta Therapeutics Q1 GAAP Loss Per Share $1.20

Published: 05/04/2022 21:31 GMT

Sarepta Therapeutics Inc (SRPT) - Q1 Non-GAAP Loss per Share $0.56.
Q1 GAAP Loss per Share $1.20.

Revenue is expected to be $220.81 Million
Adjusted EPS is expected to be -$1.11

Next Quarter Revenue Guidance is expected to be $230.55 Million
Next Quarter EPS Guidance is expected to be -$0.96

More details on our Analysts Page.